| Primary |
| Product Used For Unknown Indication |
51.3% |
| Suicide Attempt |
15.7% |
| Drug Use For Unknown Indication |
8.7% |
| Nasal Congestion |
5.2% |
| Hypersensitivity |
2.6% |
| Parkinson's Disease |
2.6% |
| Nasopharyngitis |
1.7% |
| Sinus Congestion |
1.7% |
| Analgesic Therapy |
0.9% |
| Back Pain |
0.9% |
| Common Cold |
0.9% |
| Hypotension |
0.9% |
| Middle Ear Effusion |
0.9% |
| Multiple Allergies |
0.9% |
| Pyrexia |
0.9% |
| Respiratory Tract Infection |
0.9% |
| Rhinitis Allergic |
0.9% |
| Sedation |
0.9% |
| Sinusitis |
0.9% |
| Substance Use |
0.9% |
|
| Toxicity To Various Agents |
54.5% |
| Haemorrhage |
5.5% |
| Convulsion |
3.6% |
| Subarachnoid Haemorrhage |
3.6% |
| Supraventricular Tachycardia |
3.6% |
| Therapeutic Response Unexpected |
3.6% |
| Acute Generalised Exanthematous Pustulosis |
1.8% |
| Angioedema |
1.8% |
| Colitis Ischaemic |
1.8% |
| Dizziness |
1.8% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
1.8% |
| Drug Reaction With Eosinophilia And Systemic Symptoms |
1.8% |
| Drug Toxicity |
1.8% |
| Hypertension |
1.8% |
| Mania |
1.8% |
| Middle Insomnia |
1.8% |
| Myocardial Infarction |
1.8% |
| Presyncope |
1.8% |
| Psychotic Disorder |
1.8% |
| Pulmonary Embolism |
1.8% |
|
| Secondary |
| Product Used For Unknown Indication |
18.9% |
| Suicide Attempt |
16.1% |
| Drug Use For Unknown Indication |
14.4% |
| Hypercholesterolaemia |
5.6% |
| Lower Respiratory Tract Infection |
5.6% |
| Nasal Decongestion Therapy |
5.6% |
| Otitis Media |
4.4% |
| Drug Abuse |
3.9% |
| Foetal Exposure During Pregnancy |
3.9% |
| Completed Suicide |
3.3% |
| Nasal Congestion |
2.8% |
| Intentional Self-injury |
2.2% |
| Nasopharyngitis |
2.2% |
| Sleep Apnoea Syndrome |
2.2% |
| Snoring |
2.2% |
| Cough |
1.7% |
| Sinus Headache |
1.7% |
| Eustachian Tube Disorder |
1.1% |
| Hypersensitivity |
1.1% |
| Influenza |
1.1% |
|
| Renal Impairment |
17.6% |
| Vomiting |
13.7% |
| Drug Hypersensitivity |
7.8% |
| Unresponsive To Stimuli |
7.8% |
| Haemorrhage |
5.9% |
| Toxicity To Various Agents |
5.9% |
| Completed Suicide |
3.9% |
| Drug Toxicity |
3.9% |
| Skin Test Positive |
3.9% |
| Subarachnoid Haemorrhage |
3.9% |
| Suicide Attempt |
3.9% |
| Urinary Retention |
3.9% |
| Weight Decreased |
3.9% |
| Anaphylactic Reaction |
2.0% |
| Drug Interaction |
2.0% |
| Grand Mal Convulsion |
2.0% |
| Microtia |
2.0% |
| Muscle Twitching |
2.0% |
| No Adverse Event |
2.0% |
| Panic Attack |
2.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
41.1% |
| Drug Use For Unknown Indication |
11.0% |
| Pain |
5.5% |
| Depression |
4.4% |
| Hypertension |
4.4% |
| Hypersensitivity |
3.6% |
| Nasal Congestion |
3.6% |
| Arthritis |
2.6% |
| Muscle Spasms |
2.5% |
| Nasopharyngitis |
2.4% |
| Hiv Infection |
2.2% |
| Nausea |
2.2% |
| Breast Cancer |
2.0% |
| Chemotherapy |
2.0% |
| Sinusitis |
2.0% |
| Constipation |
1.8% |
| Diabetes Mellitus |
1.8% |
| Dyspnoea |
1.6% |
| Rhinitis Allergic |
1.6% |
| Smoking Cessation Therapy |
1.6% |
|
| Urinary Tract Infection |
13.7% |
| Pulmonary Embolism |
10.5% |
| Wound Complication |
8.4% |
| Pain |
7.4% |
| Oedema Peripheral |
5.3% |
| Weight Increased |
5.3% |
| Maternal Exposure During Pregnancy |
4.2% |
| Respiratory Failure |
4.2% |
| Thrombocytopenia |
4.2% |
| Urinary Retention |
4.2% |
| Ventricular Tachycardia |
4.2% |
| Vision Blurred |
4.2% |
| Vomiting |
4.2% |
| Hy's Law Case |
3.2% |
| Nausea |
3.2% |
| Sleep Disorder |
3.2% |
| Tooth Extraction |
3.2% |
| Unresponsive To Stimuli |
3.2% |
| Bicuspid Aortic Valve |
2.1% |
| Haemorrhage Intracranial |
2.1% |
|
| Interacting |
| Infection |
50.0% |
| Nasal Congestion |
50.0% |
|
|
